WebThis Registration Rights Agreement (this “ Agreement ”) is made and entered into as of May 10, 2024, by and among Tokai Pharmaceuticals, Inc., a Delaware corporation (the “ Company ”) and each of the other parties signatory hereto (each a “ Purchaser ” and together, the “ Purchasers ”). This Agreement is made pursuant to the ... WebNovus Therapeutics, Inc.(“Novus”) is a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (“ENT”). …

Novus Therapeutics, Inc. LinkedIn

WebListed Company. "Novus Therapeutics is developng and commercializing next generation anti-CD40 Ligand (CD40L) antibodies for patients in need of a potentially life-saving treatment. With AT-1501 as the cornerstone of our pipeline, Novus is poised to leverage our expertise in both anti-CD40 Ligand biology and drug development to advance ... WebEledon Pharmaceuticals is building upon a deep historical understanding of the CD40/CD40L pathway, as well as preclinical and Phase 1 data, to initiate up to four Phase 2 clinical studies in renal transplantation, islet cell transplantation, autoimmune nephritis, and amyotrophic lateral sclerosis (ALS). christmas cities in texas

Novus Therapeutics Doses First Patients in Phase 2a Trial …

Web15 sep. 2024 · Novus Therapeutics, Inc. is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people … http://ir.novustherapeutics.com/news-releases/news-release-details/novus-therapeutics-announces-acquisition-anelixis-therapeutics Web7 sep. 2024 · My contributions were instrumental in the Alcon-Novus Vision partnership. I assisted in the preparation of two patent disclosures, … germany international dialing code from uk